For the year ending 2025-12-31, APVO has $27,194K in assets. $9,813K in debts. $21,619K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 21,619 | |||
| Prepaid expenses and other current assets | 1,462 | |||
| Total current assets | 23,081 | |||
| Property and equipment, gross | 14,446 | |||
| Less accumulated depreciation | 14,143 | |||
| Property and equipment, net | 303 | |||
| Operating lease right-of-use asset | 3,810 | |||
| Total assets | 27,194 | |||
| Accounts payable | 877 | |||
| Accrued expenses and other current liabilities | 4,307 | |||
| Operating lease liability, current portion | 866 | |||
| Total current liabilities | 6,050 | |||
| Operating lease liability, net of current portion | 3,763 | |||
| Total liabilities | 9,813 | |||
| Common stock 0.001 par value 500,000,000 shares authorized 997,830 and 4,051 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 114 | |||
| Additional paid-in capital | 292,382 | |||
| Accumulated deficit | -275,115 | |||
| Total stockholders' equity | 17,381 | |||
| Total liabilities and stockholders' equity | 27,194 | |||
Aptevo Therapeutics Inc. (APVO)
Aptevo Therapeutics Inc. (APVO)